These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26987934)

  • 1. Does the meld system provide equal access to liver transplantation for patients with different ABO blood groups?
    IJtsma AJ; van der Hilst CS; Nijkamp DM; Bottema JT; Fidler V; Porte RJ; Slooff MJ
    Transpl Int; 2016 Aug; 29(8):883-9. PubMed ID: 26987934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
    Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
    Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation.
    Györi GP; Silberhumer GR; Zehetmayer S; Kern B; Hetz H; Soliman T; Steininger R; Mühlbacher F; Berlakovich GA
    Transpl Int; 2012 Sep; 25(9):935-40. PubMed ID: 22775308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deaths on the liver transplant waiting list: an analysis of competing risks.
    Kim WR; Therneau TM; Benson JT; Kremers WK; Rosen CB; Gores GJ; Dickson ER
    Hepatology; 2006 Feb; 43(2):345-51. PubMed ID: 16440361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for long-term mortality in a large cohort of patients wait-listed for liver transplantation in Brazil.
    Basto ST; Villela-Nogueira CA; Tura BR; Coelho HS; Ribeiro J; Fernandes ES; Schmal AF; Victor L; Luiz RR; Perez RM
    Liver Transpl; 2011 Sep; 17(9):1013-20. PubMed ID: 21604358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Argentine experience with human immune deficiency virus positive patients in the waiting list for liver transplantation: preliminary analysis].
    Villamil A; Bisignano L; Orozco F; Bandi JC; Barcán L; McCormack L; Gondolesi G; Santibañes Ed; Gadano A
    Acta Gastroenterol Latinoam; 2013 Jun; 43(2):113-20. PubMed ID: 23940911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater travel time to a liver transplant center does not adversely affect clinical outcomes.
    Firozvi AA; Lee CH; Hayashi PH
    Liver Transpl; 2008 Jan; 14(1):18-24. PubMed ID: 18161800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
    Iacob S; Gheorghe L; Iacob R; Gheorghe C; Hrehoreţ D; Popescu I
    Chirurgia (Bucur); 2009; 104(3):267-73. PubMed ID: 19601457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for liver transplantation waiting list mortality.
    Fink MA; Berry SR; Gow PJ; Angus PW; Wang BZ; Muralidharan V; Christophi C; Jones RM
    J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
    Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study.
    Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Rocha-Santos V; Pinheiro RSN; Nacif LS; D'Albuquerque LAC
    Transplant Proc; 2018 Apr; 50(3):754-757. PubMed ID: 29661430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.